EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Lang wirksame Injektionstherapien: Chance und Herausforderung

Marcel Lee

MMW - Fortschritte der Medizin · 2024

DOI: 10.1007/s15006-024-3997-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MMW - Fortschritte der Medizin, 2024. Verfasst von Marcel Lee. Beteiligte Einrichtung: MVZ am Isartor, Isartorplatz 6, 80336, München, Deutschland. marcel.lee@tum.de. Hauptthemen laut MEDLINE: HIV Infections, Delayed-Action Preparations, Anti-HIV Agents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the development of an effective antiretroviral therapy (ART) in 1996, substantial progress has been made in terms of efficacy, safety and ease of use. While at the beginning of the ART era the foremost goal necessarily was patient survival, over time it has become increasingly possible to shift the focus towards aspects of patient's quality of life. The latest developments are the long-acting injection therapies (LAI), foregoing for the first time the necessity to take pills. The only available injection therapy so far comprises 2 intramuscular injections every 2 months, with 3 ml of Cabotegravir 600 mg and 3 ml of Rilpivirine 900 mg being injected, respectively. Through this, patient's needs that were hitherto precluded from consideration could be addressed. These needs are inextricably linked to the stigmata people living with HIV (PLWH) are still confronted with on a daily basis. LAI have the potential to relieve PLWH of some of the heavy psychological burdens associated with the continued stigmatization. However, as a new therapy, new challenges need to be considered the use of LAI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsDelayed-Action PreparationsAnti-HIV AgentsHumansInjections, IntramuscularRilpivirinePyridonesQuality of LifeDiketopiperazines

Stichwörter der Autor:innen

HIVLAILong-acting injection therapiesstigmatization

Substanzen

Delayed-Action PreparationsAnti-HIV AgentsRilpivirinecabotegravirPyridonesDiketopiperazines

Autor:innen und Institutionen

  • MVZ am Isartor, Isartorplatz 6, 80336, München, Deutschland. marcel.lee@tum.de.

Zitieren

APA

Lee, M. (2024). Lang wirksame Injektionstherapien: Chance und Herausforderung. MMW - Fortschritte der Medizin. https://doi.org/10.1007/s15006-024-3997-x

Vancouver

Lee M. Lang wirksame Injektionstherapien: Chance und Herausforderung. MMW - Fortschritte der Medizin. 2024. doi:10.1007/s15006-024-3997-x

BibTeX
@article{Lee2024,
  author = {Lee, Marcel},
  title = {Lang wirksame Injektionstherapien: Chance und Herausforderung},
  journal = {MMW - Fortschritte der Medizin},
  year = {2024},
  doi = {10.1007/s15006-024-3997-x}
}
Kostenlos starten →